Borealis Sells Melamine Process Technology to Urea Casale SA

Borealis announced the sale of its proprietary Melamine high pressure process technology and its newly developed super high pressure process technology and all related intellectual property rights to Urea Casale, Switzerland.

"The divestment follows an earlier strategic decision by the company to focus on the Melamine business and production, and to exit the Melamine licensing activity," said Markku Korvenranta, Executive Vice President Base Chemicals Borealis. "Engineering and technology providers in the Nitrogen industry can leverage their business activities by adding this leading technology into their portfolio."

Borealis produces Melamine at two sites in Linz, Austria and Piesteritz, Germany. These sites will be not affected by the sale. 

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.